<- Go Home

Tabula Rasa HealthCare, Inc.

As of November 2023, Tabula Rasa HealthCare, Inc. was acquired by AnewHealth. Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third-party administrator services. It serves healthcare organizations. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Market Cap

$284.0M

Volume

400.3K

Cash and Equivalents

$62.8M

EBITDA

-$37.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$79.8M

Profit Margin

23.61%

52 Week High

$10.50

52 Week Low

$3.15

Dividend

N/A

Price / Book Value

-3.44

Price / Earnings

-4.30

Price / Tangible Book Value

-1.03

Enterprise Value

$563.2M

Enterprise Value / EBITDA

-17.07

Operating Income

-$40.2M

Return on Equity

144.09%

Return on Assets

-5.98

Cash and Short Term Investments

$62.8M

Debt

$342.0M

Equity

-$78.1M

Revenue

$338.1M

Unlevered FCF

$150.1M

Sector

Health Care Technology

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches